Oversight Board

The purpose of the Oversight Board is to govern the MRCC effectively and, in doing so, to build public and stakeholder confidence that their health and healthcare is in safe hands.  

Jane Eddleston – Oversight Board Chair

Professor Eddleston is a Consultant in Intensive Care Medicine and Anaesthesia at the Manchester Royal Infirmary and is the Group Joint Medical Director for MFT. She is the Clinical Chair of the Greater Manchester Critical Care Operational Delivery Network and a member of the Faculty Board for Intensive Care Medicine. She has extensive Clinical and Managerial experience in Critical Care and Acute Care and is the Chair of the Clinical Reference Group for Adult Critical Care.

Jane Eddleston

MRCC Oversight Board Members: 

Charlotte Skitterall – CSS Group Chief Pharmacist, Celia Hogan – Infectious Diseases Consultant, David Kay – SM MCS Director of Finance, Dr Fiona Lalloo – Clinical Head of Department Genetics, Dr Iain McLean – Managing Director of Research and Innovation, Dr Katherine Boylan – MFT Director of Innovation, Dr Rachael Barber – RMCH Medical Director, Dr Sarah Vause – SM MCS Medical Director, Emma Gilbey – Programme Director for Long Term Conditions Manchester LCO, Helen Ibbott – LCOs Director of Strategy, Helen Roberts – MFT CSS Associate Director of Integration and Transformation, Ian Daniels – SM MCS Director of Business and Innovation, Jennifer Hughes – Deputy Director of Transformation NMGH, Jonathan Simpson – MRI Medical Director, Julia Birchall-Searle – RMCH Director of Nursing, Kashif Haque – MFT Director of Change, Innovation and Improvement, Prof Matthew Makin – NMGH Medical Director, Prof Michael Pemberton – Medical Director University Dental Hospital Manchester, Nichola Garde – BBC Creative Diversity and Disability Lead and Patient Representative, Prof Bill Newman – Clinical Director NW GMSA, Prof Indi Banerjee – RMCH Associate Medical Director, Prof Jane Eddleston – Group Medical Director, Dr Richard Body – Director of Research and Innovation, Rachel Ingham – Divisional Director Genomics, Dr Sarah O’Shea – Medical Director CSS, Dr Sohail Munshi – LCOs Chief Medical Officer, Stephen Dickson – RMCH Chief Executive Officer, Stuart Moore – Director of Strategic Planning MRI, Tom Rafferty – MFT Director of Strategy.